THOMAS LAMBERT: Open Payments
NPI 1649222167 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,641 in 65 payments from 20 companies in 2025. Trend: 2023 $1,064 · 2024 $881 · 2025 $1,641
Food & beverage: $1,641
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $213 |
| Amgen Inc. | 16 | $201 |
| Abbott Laboratories | 3 | $165 |
| Pacira Pharmaceuticals Incorporated | 1 | $122 |
| PFIZER INC. | 5 | $117 |
| Merck Sharp & Dohme LLC | 4 | $100 |
| Alnylam Pharmaceuticals Inc. | 3 | $88 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $86 |
| E.R. Squibb & Sons, L.L.C. | 3 | $78 |
| BridgeBio Pharma, Inc. | 3 | $76 |
Products named: REPATHA, LEQVIO, AVEIR, Exparel, VYNDAQEL, AMVUTTRA, LifeVest, Attruby.
Industry payments across NV — which companies pay providers there.
